Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006163 · ClinicalTrials.gov registry record · Phase 4
Computer-assisted Diabetes Self-management Interventions
A Phase 4 study of Diabetes Mellitus, Type 2, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- Phase 4
- Development phase
- 1
- Study location
NCT00006163 is a Phase 4 study of Diabetes Mellitus, Type 2 that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The trial reports 1 study location across 1 state.
The verdict
NCT00006163, a Phase 4 study of Diabetes Mellitus, Type 2, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1
- Study location
Study Summary
This project evaluates the effectiveness of different aspects of a program to assist type 2 diabetes patients with dietary changes. It evaluates the effectiveness of Personalized Self-Management Training and Community Resources support, using a randomized design. This study will also evaluate what percent of patients are willing to participate in such a program, and what percent of primary care physicians are willing to recommend it to their patients.
Conditions Studied
Interventions
- BEHAVIORAL Personalized Self-management
- BEHAVIORAL Community Resources
Study Locations (1)
Colorado
- AMC Cancer Research center - Denver
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-09 |
| Est. Completion | 1999-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006163
The ClinicalTrials.gov registry entry for NCT00006163 describes a study currently listed as completed, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Personalized Self-management is the first listed.
NCT00006163 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT00006163 about?
NCT00006163 is a clinical study titled "Computer-assisted Diabetes Self-management Interventions". This project evaluates the effectiveness of different aspects of a program to assist type 2 diabetes patients with dietary changes. It evaluates the effectiveness of Personalized Self-Management Training and Community Resources support, using a randomized design. This study will also evaluate what p...
What is the current status of trial NCT00006163?
This trial is currently completed. It is a Phase 4 study. The study started on 1997-09. Estimated completion is 1999-06.
What conditions does trial NCT00006163 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.
What interventions are being tested in trial NCT00006163?
The interventions under investigation include: Personalized Self-management (BEHAVIORAL), Community Resources (BEHAVIORAL).
Who is sponsoring clinical trial NCT00006163?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00006163 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
RECRUITING · Phase 4
-
Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II Diabetes
RECRUITING · Phase 4
-
Effect of Continuing Versus Holding Metformin During Hospitalizations.
RECRUITING · Phase 4
-
Surgical or Medical Treatment
ACTIVE NOT RECRUITING · Phase 4
-
Afrezza® Dosing Optimization Study
COMPLETED · Phase 4
-
Effect of Thiazolidinedione Treatment Vascular Risk Markers
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.